Myomo (MYO) Shares Outstanding (Weighted Average) (2016 - 2025)
Myomo (MYO) reported Shares Outstanding (Weighted Average) of $38.5 million for Q4 2025, up 1.89% on a YoY basis from $37.8 million in Q4 2024, and down 8.77% quarter-over-quarter from $42.2 million in Q3 2025.
Myomo (MYO) Shares Outstanding (Weighted Average) (2016 - 2025) Analysis & Trends
Myomo has reported Shares Outstanding (Weighted Average) for 10 years, with the latest figure at $38.5 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 1.89% year-over-year to $38.5 million; the trailing twelve-month figure through Dec 2025 stood at $38.5 million (up 1.89% YoY), and the FY2025 full-year result was $38.5 million, up 1.89% from the prior year.
- Shares Outstanding (Weighted Average) for Q4 2025 stood at $38.5 million, down from $42.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $42.2 million in Q3 2025, with the low at $1191.0 in Q1 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $18.5 million across 5 years, with a median of $8.0 million in 2022.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) tumbled 99.0% — and 2022, when it surged 578063.22%.
- Myomo's Shares Outstanding (Weighted Average) stood at $693643.0 in 2021, then slipped by 1.91% to $680363.0 in 2022, then surged by 1213.97% to $8.9 million in 2023, then jumped by 322.37% to $37.8 million in 2024, then rose by 1.89% to $38.5 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $38.5 million (Q4 2025), $42.2 million (Q3 2025), and $41.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | 38.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.47 Mn |
| Sep 30, 2025 | 42.17 Mn |
| Jun 30, 2025 | 41.58 Mn |
| Mar 31, 2025 | 41.45 Mn |
| Dec 31, 2024 | 37.76 Mn |
| Sep 30, 2024 | 37.36 Mn |
| Jun 30, 2024 | 37.37 Mn |
| Mar 31, 2024 | 224,730.00 |
| Dec 31, 2023 | 8.94 Mn |
| Sep 30, 2023 | 27.54 Mn |
| Jun 30, 2023 | 27.99 Mn |
| Mar 31, 2023 | 6.83 Mn |
| Dec 31, 2022 | 680,363.00 |
| Sep 30, 2022 | 7.06 Mn |
| Jun 30, 2022 | 6.90 Mn |
| Mar 31, 2022 | 6.89 Mn |
| Dec 31, 2021 | 693,643.00 |
| Sep 30, 2021 | 118,696.00 |
| Jun 30, 2021 | 118,696.00 |
| Mar 31, 2021 | 1,191.00 |